Skip to main content
. 2017 Apr 19;6:10–21. doi: 10.1016/j.omto.2017.04.001

Figure 3.

Figure 3

Treatment of Four Different Pancreatic Tumor Cell Lines with Increasing Concentrations of nab-Paclitaxel

Remaining tumor cell masses were analyzed at 72 hr after initiation of treatment with nab-paclitaxel by sulforhodamine B assays (n = 3, mean and SD are shown). Dotted lines indicate a tumor cell mass of 75% being remnant at 72 hr post-initiation of nab-paclitaxel treatment.